1-9 of 9
plaque psoriasis
Close
Sort by
Journal Articles

IL-17-Driven Immune Signaling in Autoimmunity and Fungal Infections

Sarah Gaffen, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): SCI-48.
https://doi.org/10.1182/blood.V130.Suppl_1.SCI-48.SCI-48
Published: 2017
Journal Articles

IMO-8400, an Antagonist of Toll-like Receptors 7, 8, and 9, in Development for Genetically Defined B-Cell Lymphomas: Safety and Activity in Phase 1 and Phase 2 Clinical Trials

Louis Brenner, MD MBA, Robert D. Arbeit, MD, Tim Sullivan, PhD
Journal: Blood
Blood (2014) 124 (21): 3101.
https://doi.org/10.1182/blood.V124.21.3101.3101
Published: 2014
Journal Articles

Highly Elevated IL-18 Is a Reliable Predictor of Progression to Hemophagocytic Syndrome in the Patients with Langerhans Cell Histiocytosis

Yasuhiro Ikawa, MD PhD, Raita Araki, MD, Toshihiro Fujiki, MD, Masaki Fukuda, MD, Shintaro Mase, MD, Rie Kuroda, MD, Hideaki Maeba, MD, Shoichi Koizumi, MD PhD, Akihiro Yachie, MD PhD, Ryosei Nishimura, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2736.
https://doi.org/10.1182/blood.V124.21.2736.2736
Published: 2014
Journal Articles

Adhesion Molecule Blockade with the Humanized Anti-LFA-1 Monoclonal Antibody Efalizumab Improves Steroid Refractory Acute and Chronic Graft-Versus-Host Disease of the Skin

James M. Coghill, MD, Kristine E. Nograles, MD, James G. Krueger, MD, PhD, Amy S. Coghill, RN, MSN, Jonathan S. Serody, MD, PhD, Anastasia Ivanova, PhD, Julia Whitley, BS, Donald Gabriel, MD, PhD, Terrance Comeau, MD, Thomas Shea, MD
Journal: Blood
Blood (2008) 112 (11): 4350.
https://doi.org/10.1182/blood.V112.11.4350.4350
Published: 2008
Journal Articles

Efalizumab-Induced Autoimmune Hemolytic Anemia

Patrick Lee, MD, Alexandra Schwarsin, MD, Joao L. Ascensao, MD, PhD, Geraldine P. Schechter, MD
Journal: Blood
Blood (2008) 112 (11): 5375.
https://doi.org/10.1182/blood.V112.11.5375.5375
Published: 2008
Journal Articles

A Phase II Study of the Purine Nucleoside Phosphorylase (PNP) Inhibitor RO5092888 (BCX-4208) in Patients with Moderate to Severe Chronic Plaque Psoriasis: Safety, Tolerability and Lymphocyte Effects

Joseph P Gomes, PharmD, MS, BCPS, Angela Georgy, Sharon Passe, Adrienne Farid, Shanta Bantia, PhD, Gerhard Wolff
Journal: Blood
Blood (2008) 112 (11): 2583.
https://doi.org/10.1182/blood.V112.11.2583.2583
Published: 2008
Journal Articles

A Phase II Multiple Dose Clinical Trial of Histone Deacetylase Inhibitor ITF2357 in Patients with Relapsed or Progressive Multiple Myeloma: Preliminary Results.

Monica Galli, MD, PhD, Silvia Salmoiraghi, PhD, Josée Golay, PhD, Antonella Gozzini, MD, Alberto Bosi, MD, Claudia Crippa, MD, Giuseppe Rossi, MD, Norbert Pescosta, MD, Sergio Cortelazzo, MD, Alessandra Sechi, PhD, Tiziano Oldoni, MD, Alessandro Rambaldi, MD
Journal: Blood
Blood (2007) 110 (11): 1175.
https://doi.org/10.1182/blood.V110.11.1175.1175
Published: 2007
Journal Articles

Erratum for vol. 95, p. 3635

Journal: Blood
Blood (2001) 97 (6): 1533.
https://doi.org/10.1182/blood.V97.6.1533
Published: 2001
Journal Articles

Variable course of patients with plaque psoriasis: lack of transformation into tumorous mycosis fungoides

Silke Stachowitz, Martin Mempel, Christian Schmöckel, Rita von Spanyi, Dietrich Abeck
Journal: Blood
Blood (2000) 95 (11): 3635–3636.
https://doi.org/10.1182/blood.V95.11.3635
Published: 2000